South Korea · Delayed Price · Currency is KRW Protia Company Description
Protia Inc. designs, develops, and sells diagnostic kits in South Korea.
The company offers PROTIA Allergy-Q, an assay kit for quantitative determination of specific IgE antibodies against individual allergens in human serum using immunoblotting technique; ImmuneCheck IgG, a whole blood test kit for total IgG concentration measurement; and TriCheck-C, an in vitro diagnostic kit for the qualitative test of human chorionic gonadotropin in human urine samples for the pregnancy diagnosis.
It also provides protia food iga, a chronic food intolerance test to identify the foods that do not fit, and stay healthy; anitia canine ige, a serum to identify the cause of the allergy; anicheck bovine igg, a colostrum for feeding calves.
In addition, the company provides genedania, a kit for the detection of nucleic acid from SARS-CoV-2.
Further, it offers 2-D electrophoresis, mass spectrometry, post translational, and protein services. The company was formerly known as ProteomeTech Inc. and changed its name to Protia Inc. in November 2023.
Protia Inc. was founded in 2000 and is based in Seoul, South Korea.
| Country | South Korea |
| Founded | 2000 |
| Industry | In Vitro and In Vivo Diagnostic Substances |
| CEO | Kook Jin Lim |
Contact Details
Address: A-702, 401 Yangcheon-ro Seoul, 07528 South Korea | |
| Phone | 82 2 6968 5288 |
| Website | protia.co.kr |
Stock Details
| Ticker Symbol | 303360 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Kook Jin Lim | Chief Executive Officer |